Trump Says He'll Try to Rid U.S. of Daylight Saving Time
By Robin Foster HealthDay Reporter
MONDAY, Dec. 16, 2023 -- President-elect Donald Trump is calling for an end to daylight saving time, a practice he described as inconvenient and costly.
“The Republican Party will use its best efforts to eliminate Daylight Saving Time, which has a small but strong constituency, but shouldn’t!” Trump wrote in an X post on Friday.
The biannual clock change, which has been used in the United States since World War II, is meant to make the most of daylight hours during the summer months. However, it has faced criticism for its impact on health, productivity, and overall convenience.
Efforts to eliminate daylight saving time have come up in Congress before, most notably through the stalled Sunshine Protection Act. Sponsored by Florida Sen. Marco Rubio, the bipartisan bill sought to make daylight saving time permanent nationwide.
Trump has tapped Rubio to lead the State Department in his new administration.
"Changing the clock twice a year is outdated and unnecessary,” said Republican Sen. Rick Scott of Florida when the Senate first approved the Sunshine Protection Act in 2022, according to an AP News report.
Most of the world does not observe daylight saving time, and some U.S. states already opt out. Both Arizona and Hawaii remain on standard time year-round.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-17 00:00
Read more
- Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use Disorder
- Linerixibat Shows Positive Phase III Results in Cholestatic Pruritus in Primary Biliary Cholangitis (PBC)
- Most With Intractable Meniere Disease Experience Symptom Relief
- 'Brain Boost' From Today's Exercise May Linger Through Tomorrow
- E. Coli Fears Spur Recall of 167,000 Pounds of Ground Beef
- Cassava Sciences Topline Phase 3 Data for Simufilam Did Not Meet Co-Primary Endpoints
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions